ANXA2 and breast carcinoma: Annexin A2 has been reported to be highly upregulated in the cells of multiple types of cancer (including breast cancer), with an especially higher expression in the invasive triple-negative MDA-MB-231 cell line compared to the noninvasive luminal cell line MCF-7 (20, 30).